No study has comprehensively evaluated the performance of 28S nrDNA and ITS sequencing, commercial biochemical test kits, MALDI-TOF MS platforms, and the emerging rep-PCR DNA fingerprinting technology using a cohort of yeast strains collected from a clinical microbiology laboratory. In this study, using 71 clinically important yeast isolates (excluding Candida albicans) collected from a single centre, we determined the concordance of 28S nrDNA and ITS sequencing and evaluated the performance of two commercial test kits, two MALDI-TOF MS platforms, and rep-PCR DNA fingerprinting. 28S nrDNA and ITS sequencing showed complete agreement on the identities of the 71 isolates. Using sequencing results as the standard, 78.9% and 71.8% isolates were correctly identified using the API 20C AUX and Vitek 2 YST ID Card systems, respectively; and 90.1% and 80.3% isolates were correctly identified using the Bruker and Vitek MALDI-TOF MS platforms, respectively. Of the 18 strains belonging to the Candida parapsilosis species complex tested by DiversiLab automated rep-PCR DNA fingerprinting, all were identified only as Candida parapsilosis with similarities ≥93.2%, indicating the 
misidentification of Candida metapsilosis and Candida orthopsilosis. However, hierarchical cluster analysis of the rep-PCR DNA fingerprints of these three species within this species complex formed three different discrete clusters, indicating that this technology can potentially differentiate the three species. To achieve higher accuracies of identification, the databases of commercial biochemical test kits, MALDI-TOF MS platforms, and DiversiLab automated rep-PCR DNA fingerprinting needs further enrichment, particularly for uncommonly encountered yeast species.
INTRODUCTION
Identification of yeasts in clinical microbiology laboratories is traditionally performed by phenotypic tests, such as microscopic appearance after Gram-smear, germ tube production, and biochemical tests. However, these phenotypic tests may result in ambiguous biochemical profiles and hence "difficult-to-identify" isolates. Since the advancement of molecular technologies, sequencing of conserved DNA regions has been used as the standard for identifying these "difficult-to-identify" yeasts. The most widely used and accepted molecular targets for yeast identification are the 28S nuclear ribosomal DNA (nrDNA) and internal transcribed spacer (ITS) region comprising the ITS1-5.8S nrDNA-ITS2 gene cluster. [1] [2] [3] In the last few years, matrix-assisted laser desorption/ionisation-time of flight mass spectrometry (MALDI-TOF MS), which has been used for identification of bacteria successfully, has also been employed for rapid identification of yeasts. 4, 5 Recently, a new technology, named repetitive sequence-based polymerase chain reaction (rep-PCR) DNA fingerprinting, has emerged as a rapid method for the discrimination of various clinical yeasts. 6 Although the performance of some commercial systems for yeast identification has been individually compared with sequence-based method, [7] [8] [9] so far, no study has comprehensively evaluated the performance of 28S nrDNA and ITS sequencing, commercial biochemical test kits, MALDI-TOF MS platforms, and rep-PCR DNA fingerprinting altogether using a cohort of yeast strains collected from a clinical microbiology laboratory. In this study, we determined the concordance of 28S nrDNA and ITS sequencing and used them as the gold standard for identifying yeasts collected from a clinical microbiology laboratory. Using this standard, the performance of two commercial biochemical test kits, two MALDI-TOF MS platforms, and the emerging rep-PCR DNA fingerprinting technology were evaluated. 12 respectively. The PCR products were agarose gel-purified and sequenced in both directions using primers the same as those used for PCR amplification by Tsingke Biological Technology (China) with the 3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, USA). The sequence electropherograms were checked manually to ensure the sequencing results were of high quality. 
Methods

Yeast isolates
Sequence-based species identification
The ITS and partial 28S nrDNA sequences of each yeast isolate were queried against sequences in the Westerdijk Fungal Biodiversity Institute database by pairwise alignment (http://www.westerdijkinstitute.nl/Collections/Biolo MICSSequences.aspx) for species identification.
Biochemical profiling
The biochemical profiles of the yeast isolates were characterized using the API 20C AUX system (bioMérieux, France) and the Vitek 2 YST ID Card system (bioMérieux) according to the manufacturer's instructions. For the API 20C AUX system, identifications of the isolates were only accepted if the per cent identities were greater than 90 with T indexes larger than 0.75; while for the Vitek 2 YST ID Card system, identifications of the isolates were only accepted if there was only one selected organism for each isolate with identification probability of greater than 93%. Isolates with top match scores of ≥2.0 were considered to be successfully identified down to the species level. Isolates with top match scores of < 2.0 but ≥1.7 were considered to be successfully identified down to the genus level only. Isolates with top match scores of < 1.7 were considered to be unidentifiable by Bruker Daltonics MALDI-TOF MS. For isolates with multiple identifications where the top match score for each of the identifications was greater than 2.0, these isolates were considered to be identified to the genus level only. For the Vitek MS platform, the isolates were characterized according to our previous publication, 10 and results with confidence values ≥60.0% were accepted for species level identification.
MALDI-TOF MS
DiversiLab automated repetitive sequence-based PCR (rep-PCR) DNA fingerprinting
Isolates of the Candida parapsilosis species complex and the reference strain Candida parapsilosis ATCC 22019 T were characterized by the DiversiLab automated rep-PCR DNA fingerprinting system to evaluate its capacity for species identification. Briefly, for each yeast isolate, genomic DNA was extracted using the UltraClean Microbial DNA Isolation Kit and repetitive sequences were amplified from the genomic DNA using the DiversiLab Yeast Fingerprint Kit (bioMérieux) following the manufacturer's protocol. Detection and analysis of the rep-PCR products were performed using the DiversiLab software version 3.4 (bioMérieux) implemented in the DiversiLab system (bioMérieux), where Pearson correlation coefficient and unweighted pair group method with arithmetic mean (UPGMA) were used to compare the rep-PCR DNA fingerprints of the yeast isolates. Species identification of an isolate was given if its rep-PCR DNA fingerprint possessed at least 90% similarities to one or more strains of a particular species in the Candida library. The rep-PCR DNA fingerprints of these yeast isolates were also visualised as electropherograms and analyzed by hierarchical cluster analysis (HCA) for generation of dendrogram using the DiversiLab software.
Nucleotide sequence accession numbers
The ITS and 28S nrDNA sequences of the 71 yeast isolates included in the present study have been deposited in the International Nucleotide Sequence Databases (INSD) with the accession numbers JN391273-JN391335, LC042127-LC042133, LC042135-LC042148, and LC088212-LC088214 (ITS), as well as JN391336-JN391406 (28S nrDNA).
Results
Concordance of molecular identification using 28S nrDNA and ITS sequences
The identities of the 71 yeast isolates were confirmed by sequencing of the 28S nrDNA and ITS. The identification results based on 28S nrDNA sequencing were in complete agreement with those based on ITS sequencing. The 71 isolates belonged to 18 different yeast species (Cryptococcus Table 1 ). The DNA sequencing-based identities were then used as the reference standards to evaluate the performance of other commercially available identification systems.
Biochemical profiling
Out of the 71 isolates, 56 (78.9%) and 51 (71.8%) isolates were correctly identified using the API 20C AUX and Vitek 2 YST ID Card systems, respectively (Table 1) . Forty-nine isolates (69.0%) could be correctly identified by both systems. Seven isolates (9.9%) could only be correctly identified by the API 20C AUX system, while two isolates (2.8%) could only be correctly identified by the Vitek 2 YST ID Card system. For the API 20C AUX system, 11 isolates (15.5%) were misidentified as other yeast species, one isolate (1.4%) was identified as "unidentified organism", and three isolates (4.2%) could not be identified due to low discrimination values; while for the Vitek 2 YST ID Card system, 13 isolates (18.3%) were misidentified as other yeast species, one isolate (1.4%) was identified as "unidentified organism," and six isolates (8.5%) could not be identified due to low discrimination values. Generally, even using a combination of both systems, correct identification could not be achieved for one of the Cryptococcus neoformans isolate (PUMY046). Both Candida metapsilosis (PUMY018) and Candida orthopsilosis (PUMY022 and PUMY023) were misidentified as Candida 
MALDI-TOF MS
Among the 71 isolates, 65 (91.5%) and 57 (80.3%) isolates were successfully identified to the correct species using the Bruker and Vitek platforms, respectively (Table 1) . Fifty-four isolates (76.1%) could be correctly identified by both platforms. Eleven isolates (15.5%) could only be correctly identified by the Bruker platform, while three isolates (4.2%) could only be correctly identified by the Vitek platform. For the Bruker platform, five isolates (7.0%) were misidentified as other yeast species, and no identification was provided for one isolate (1.4%); while for the Vitek platform, two isolates (2.8%) were misidentified as other yeast species, multiple identifications were provided for three isolates (4.2%), and no identification was provided for nine isolates (12.7%). Although Candida metapsilosis (PUMY018) and Candida orthopsilosis (PUMY022 and PUMY023) could be correctly identified using the Bruker platform, these two species were not correctly identifiable using the Vitek platform. Correct identification for one Cryptococcus neoformans isolate (PUMY046), one E. dermatitidis isolate (PUMY064), and Trichosporon jirovecii (PUMY071) could not be achieved using both platforms.
DiversiLab automated rep-PCR DNA fingerprinting
Of the 17 clinical isolates and one reference strain (ATCC 22019 T ) belonging to the Candida parapsilosis species complex, all were identified by DiversiLab automated rep-PCR DNA fingerprinting only as Candida parapsilosis with similarities ≥93.2% (Table 2) , indicating the misidentification of Candida metapsilosis and Candida orthopsilosis. However, HCA of the rep-PCR DNA fingerprints of these three species within this species complex formed three different discrete clusters (Fig. 2) .
Discussion
When DNA sequencing of conserved molecular targets was used for fungal identification, the variable domains 1 and 2 (D1/D2 regions) of the 28S nrDNA have been utilised for species identification and phylogenetic inference of yeasts. 1 As a result, an abundant set of 28S nrDNA sequence data is available at public nucleotide repositories, such as the INSD. On the other hand, the ITS region has also been used as an alternative marker for yeast identification lately, 3, 13 and it was found that the ITS could provide an even better resolution for species identification. 14 More recently, the ITS region has been adopted as the universal DNA barcode for fungi. 15 In this study, we confirmed that there is 100% concordance between the identification results of 28S nrDNA and ITS sequencing for all the 71 clinically important yeast strains not readily identifiable by CHROMagar, although six of the 71 strains possessed multiple ITS copies and required cloning of the PCR products and subsequent sequencing for unambiguous identification. 16 These identifications were used as the gold standard for subsequent evaluation of the other identification methods.
It is important to note that one of the most critical steps for correct species identification by DNA sequencing is the accuracy of the sequence data in the databases. Therefore, curated databases, such as the Westerdijk Fungal Biodiversity Institute database, which we have used in this study, or the International Society for Human and Animal Mycology (ISHAM) ITS database, 17 should be utilized in order to obtain reliable identification results. Both the API 20C AUX and Vitek 2 YST ID Card systems were suboptimal in identifying rarely encountered yeasts. In this study, both biochemical profiling systems only performed moderately well in identifying clinical yeast isolates (70-80% identification rates). The performance of the two systems were similar (P = .4363, Fisher's exact test). In general, more frequently encountered yeast In general, for most commercial systems, around 56-89% of the studied yeast isolates were successfully identified, depending on the spectrum of yeast species that were included in the particular study, and the yeast species that were misidentified usually include those that were uncommonly encountered in clinical samples, such as Candida famata, Candida intermedia, Candida nivariensis, Candida pulcherrima, Candida zelanoides, and so forth. 18, 19 In this study, the uncommon clinical yeast E. dermatitidis (PUMY063 and PUMY064) could not be correctly identified by both commercial biochemical kits. This is because reference profiles for this species are not included in the databases of the API 20C AUX system nor the Vitek 2 YST ID Card system. This illustrates that the data volume of these biochemical profiling kits should be expanded to cover more yeast species so as to even allow the correct identification of uncommonly encountered clinical yeasts using these commercial biochemical kits. As for the particularly difficultto-identify Cryptococcus neoformans isolate PUMY046 by multiple methods, it was recovered from the cerebrospinal fluid of a 64-year-old man with chronic meningitis. Cerebrospinal fluid for cryptococcal antigen was also positive. Review of the API 20C AUX and Vitek 2 YST ID card biochemical profiles of PUMY046 revealed that the abilities of this isolate to assimilate glycerol and L-arabinose as well as L-malate, D-amygdalin, and D-gluconate respectively might have led to the failure of identifying it correctly as Cryptococcus neoformans (Table 1) . MALDI-TOF MS, coupled with hierarchical cluster analysis, is a promising technology for the rapid and accurate identification of microorganisms in clinical laboratories, provided that there is a sufficiently-sized reference database. The usefulness of MALDI-TOF MS has been greatly evaluated for the correct identification of clinical bacteria, and the application of this technology has been proven to be successful. 20 Besides pathogenic bacteria, a number of studies have attempted to evaluate the performance of MALDI-TOF MS platforms for the identification of clinical yeast isolates. 18, 21, 22 However, the use of MALDI-TOF MS for clinical mycology moves in a much slower pace than that for the identification of clinical bacteria, 20 and more evaluation on this technology is required before it is widely adopted for clinical fungi identification. 23 -25 Similar to MALDI-TOF MS, the database of DiversiLab automated rep-PCR DNA fingerprinting needs further improvement. For rep-PCR, various noncoding, repetitive sequences of different lengths in the genome are amplified. Following microfluidics electrophoresis, the amplified products are separated to generate DNA fingerprints. Since different microorganisms possess different sets of repetitive sequences and so by comparing the DNA fingerprints with those in the database unknown isolates could be identified. 26 So far, only seven studies have attempted to utilise the DiversiLab system to achieve strain differentiation or typing of yeasts, with an emphasis on Candida species, 6, [27] [28] [29] Cryptococcus neoformans/Cryptococcus gatti, 30, 31 
